MedPlus Health Services Limited (NSE:MEDPLUS)
India · Delayed Price · Currency is INR 598.00
-11.40 (-1.87%)
Oct 29, 2026, 3:30 PM IST
MedPlus Health Services Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 75,951 | 68,925 | 61,361 | 56,249 | 45,576 | 37,793 | |
Revenue Growth | 20.69% | 12.33% | 9.09% | 23.42% | 20.59% | 23.13% |
Cost of Revenue | 56,791 | 51,136 | 46,656 | 44,105 | 35,758 | 29,938 |
Gross Profit | 19,160 | 17,789 | 14,705 | 12,143 | 9,818 | 7,855 |
Selling, General & Admin | 9,722 | 8,940 | 7,441 | 6,508 | 5,565 | 4,010 |
Other Operating Expenses | 2,874 | 2,602 | 2,263 | 1,970 | 1,476 | 1,025 |
Operating Expenses | 15,701 | 14,371 | 12,202 | 10,721 | 8,857 | 6,228 |
Operating Income | 3,459 | 3,418 | 2,502 | 1,423 | 960.92 | 1,627 |
Interest Expense | -1,342 | -1,205 | -1,026 | -964.33 | -830.27 | -664.28 |
Interest & Investment Income | 433.68 | 433.68 | 259.91 | 209.36 | 277.88 | 137.32 |
Currency Exchange Gain (Loss) | - | - | 0.27 | 0.36 | 0.9 | -0.08 |
Other Non Operating Income (Expenses) | 63.84 | 63.84 | 24.76 | 25.21 | 23.65 | 42.3 |
EBT Excluding Unusual Items | 2,614 | 2,711 | 1,761 | 693.29 | 433.08 | 1,142 |
Gain (Loss) on Sale of Assets | -7.87 | -7.87 | -8.47 | -4.53 | -3.54 | -1.82 |
Asset Writedown | 34.97 | 34.97 | 66.67 | 45.22 | 42 | 38.18 |
Pretax Income | 2,656 | 2,753 | 1,832 | 734.43 | 471.63 | 1,179 |
Income Tax Expense | 546.56 | 557.24 | 330.56 | 78.66 | -29.42 | 232.27 |
Earnings From Continuing Operations | 2,110 | 2,196 | 1,501 | 655.77 | 501.05 | 947.16 |
Minority Interest in Earnings | 0.44 | 0.43 | 0.89 | -1.04 | -3.42 | 10.86 |
Net Income | 2,110 | 2,196 | 1,502 | 654.73 | 497.63 | 958.02 |
Net Income to Common | 2,110 | 2,196 | 1,502 | 654.73 | 497.63 | 958.02 |
Net Income Growth | 8.16% | 46.18% | 129.46% | 31.57% | -48.06% | 50.02% |
Shares Outstanding (Basic) | 120 | 120 | 120 | 119 | 119 | 112 |
Shares Outstanding (Diluted) | 120 | 120 | 120 | 120 | 120 | 112 |
Shares Change | -0.22% | 0.06% | -0.00% | 0.31% | 6.38% | 3.82% |
EPS (Basic) | 17.65 | 18.33 | 12.56 | 5.48 | 4.17 | 8.55 |
EPS (Diluted) | 17.63 | 18.29 | 12.52 | 5.45 | 4.17 | 8.52 |
EPS Growth | 8.46% | 46.09% | 129.72% | 30.70% | -51.06% | 44.65% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 1,847 | 3,726 | 4,810 | 593.38 | -785.97 | 521.68 |
Free Cash Flow Per Share | 15.43 | 31.02 | 40.07 | 4.94 | -6.57 | 4.64 |
Gross Margin | 25.23% | 25.81% | 23.96% | 21.59% | 21.54% | 20.78% |
Operating Margin | 4.55% | 4.96% | 4.08% | 2.53% | 2.11% | 4.30% |
Profit Margin | 2.78% | 3.19% | 2.45% | 1.16% | 1.09% | 2.54% |
Free Cash Flow Margin | 2.43% | 5.41% | 7.84% | 1.05% | -1.73% | 1.38% |
EBITDA | 4,271 | 4,171 | 3,239 | 2,085 | 1,412 | 1,867 |
EBITDA Margin | 5.62% | 6.05% | 5.28% | 3.71% | 3.10% | 4.94% |
D&A For EBITDA | 812.14 | 752.75 | 736.28 | 661.89 | 450.6 | 240.1 |
EBIT | 3,459 | 3,418 | 2,502 | 1,423 | 960.92 | 1,627 |
EBIT Margin | 4.55% | 4.96% | 4.08% | 2.53% | 2.11% | 4.30% |
Effective Tax Rate | 20.58% | 20.24% | 18.04% | 10.71% | - | 19.69% |
Revenue as Reported | 76,664 | 69,638 | 61,847 | 56,649 | 46,037 | 38,106 |
Advertising Expenses | - | 94.46 | 179.01 | 252.1 | 112.6 | 67.82 |